HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 532,795 shares of the company’s stock after selling 2,833 shares during the quarter. HCA Healthcare comprises approximately 1.1% of Fort Washington Investment Advisors Inc. OH’s portfolio, making the stock its 24th biggest position. Fort Washington Investment Advisors Inc. OH owned approximately 0.20% of HCA Healthcare worth $171,176,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after buying an additional 60,304 shares during the last quarter. Sanders Capital LLC lifted its stake in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after buying an additional 456,738 shares during the last quarter. Wellington Management Group LLP lifted its stake in HCA Healthcare by 1.7% in the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after buying an additional 170,560 shares during the last quarter. Royal Bank of Canada lifted its stake in HCA Healthcare by 35.7% in the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after buying an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors lifted its stake in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

HCA has been the subject of several analyst reports. JPMorgan Chase & Co. upped their price target on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research note on Thursday, May 30th. UBS Group upped their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research note on Wednesday, August 14th. Wells Fargo & Company upped their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Royal Bank of Canada upped their price target on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Finally, Leerink Partners upped their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $356.17.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now owns 9,454 shares in the company, valued at approximately $3,436,623.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,844 shares of company stock worth $3,185,932. 1.60% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of HCA stock traded up $2.80 during mid-day trading on Friday, reaching $395.59. The stock had a trading volume of 884,271 shares, compared to its average volume of 1,126,563. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $395.91. The company has a market cap of $103.61 billion, a P/E ratio of 19.72, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The business has a 50-day simple moving average of $348.60 and a 200 day simple moving average of $332.96. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the business posted $4.29 earnings per share. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.43 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.